SCHEMBL4603470

SCHEMBL4603470

[NH]C(=O)Cn1ccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7241523 0.82 ALDH1A1 (0.72)
SCHEMBL77978 0.80
SCHEMBL6953219 0.79 EGLN3 (0.69)
SCHEMBL27785516 0.78 ALDH1A1 (0.96)
Bromide SCHEMBL6988476 0.78 ALDH1A1 (0.96)
SCHEMBL85945 0.78
SCHEMBL1179222 0.78
SCHEMBL28119672 0.78 ALDH1A1 (0.96)
Hydrochloric Acid SCHEMBL1904485 0.78 ALDH1A1 (0.96)
SCHEMBL412255 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1768978-B1 2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-07-09 EP disclosed
US-20080058332-A1 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer ASTRAZENECA AB (SE) 2008-03-06 US disclosed